New Product Or Brand Launch
What: New Products: 3
“Commercialised the production of three new products: Toluloxy benzyl amine hydrochloride, Dichloroprop-P and Chlorsulfuron.”
In , Atul Ltd (Dyes & Pigments) is outperforming Nifty 500 with +11.1% relative strength. Fundamentals: Strong. On a 12-week streak.
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
Based on Q3 FY26 earnings • Updated Apr 18, 2026
What: New Products: 3
“Commercialised the production of three new products: Toluloxy benzyl amine hydrochloride, Dichloroprop-P and Chlorsulfuron.”
What: Capacity Increase: 830 TPA / 475 TPM
“Increased capacity of Multigrip Resin by about 830 TPA, and the RACL plant by about 475 TPM.”
What: CEP Granted: Valacyclovir
“Atul Bioscience received the CEP for Valacyclovir.”
What: PAT growth of 40% YoY
“PAT 164 182 (10%) 117 40% 478 369 30% PAT% 10% 12% (2%) 8% 2% 10% 9% 1%”
Earnings deceleration risks from management commentary
Trigger: Profitability in Life Science Chemicals was driven by improved product mix.
Management view: Focusing on improved product mix in Pharmaceuticals and Crop Protection.
Monitor: commodity
Key quotes from recent conference calls
“Q2 revenue improved quarter-over-quarter, led by increased domestic sales of Liquid Epoxy Resins (LER), dyes, pigments and 2,4-D products. [Previous Revenue Growth Drivers guidance]”
“Commercialised the production of three new products: Toluloxy benzyl amine hydrochloride, Dichloroprop-P and Chlorsulfuron. [Initiative: New Product Commercialisation]”
“Executed a 13.2 MW hybrid power agreement under a group captive arrangement with M/s Torrent Urja 39 Pvt Ltd [Initiative: Hybrid Power Agreement]”
“Higher sales and an improved product mix in the Pharmaceuticals and Crop Protection sub-segments have driven better profitability [Risk (commodity): MEDIUM]”
Headline numbers from the latest earnings call
Revenue
₹1,574 cr
Why: Revenue growth was driven by an 11% year-over-year increase compared to Q3 2024-25.
Revenue showed steady year-over-year growth but remained relatively flat on a sequential basis.
EBITDA
₹286 cr
Why: EBITDA grew 19% year-over-year but declined 9% sequentially from Q2 FY26.
Margins compressed by 200 basis points compared to the previous quarter.
PAT
₹164 cr
Why: PAT increased significantly year-over-year by 40% but saw a 10% sequential decline.
The year-over-year performance remains strong despite the quarter-on-quarter dip.
Other Highlights
• 9-month PAT grew 30% to ₹478 cr
• EPS for Q3 stood at ₹55
• Life Science Chemicals PBIT margin maintained at 20%
Sub-sector-specific signals from the latest concall — each with management's stated reason for the change
Captive Power Plant Capacity
73 MW
Production Sites
8
Why: Maintained current infrastructure.
Number of Brands
140
Why: Stable brand portfolio.
Industries Served
30
Why: Broad market presence maintained.
Number of Customers
4,000
Why: Customer base remains stable.
Products and Formulations
900 + 400
Why: Product portfolio remains consistent.
Countries Present
88
Why: Global footprint maintained.
Effluent Treatment Capacity
32 MLD
Why: Environmental infrastructure maintained.
Forward-looking targets from management
Capex Plan
₹1200 Cr
₹1,200 cr
Surplus funds available for future expansion
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +15% | +5% | Stable |
| PAT (Net Profit) | +62% | +11% | Accelerating |
| OPM | 17.0% | +200 bps | Expanding |
The above analysis is parsed from publicly available earnings call transcripts. This is educational research only — not investment advice. Last updated Apr 18, 2026.
Based on publicly available financial data. This is educational research, not investment advice.
Atul Ltd's latest quarterly results (Mar 2026) show
Atul Ltd's profit is growing with an accelerating trend.
Atul Ltd's revenue growth trend is stable.
Atul Ltd's operating margin is expanding.
Atul Ltd's long-term compounding rates
Atul Ltd's earnings growth is accelerating with mixed signals on a sequential basis.
Atul Ltd's trailing twelve month (TTM) performance
Atul Ltd appears significantly undervalued based on our fair value analysis.
Atul Ltd's current PE ratio is 29.6x.
Atul Ltd's current PE is 29.6x.
Atul Ltd's price-to-book ratio is 3.2x.
Atul Ltd is rated Strong with a fundamental score of 60.61/100. This score is calculated from objective financial metrics
Atul Ltd has a debt-to-equity ratio of N/A.
Atul Ltd's return ratios over recent years
Atul Ltd's operating cash flow is positive (FY2026).
Atul Ltd's current dividend yield is 0.37%.
Atul Ltd's shareholding pattern (Mar 2026)
Atul Ltd's promoter holding has remained stable recently.
Atul Ltd has been outperforming Nifty 500 for 12 consecutive weeks, indicating strong sustained outperformance.
Atul Ltd is an established outperformer with 12 weeks of consecutive Nifty 500 outperformance.
Atul Ltd has 4 key growth catalysts identified from recent earnings analysis
Atul Ltd has 1 key risk worth monitoring
In Q3 FY26, Atul Ltd's management highlighted
Atul Ltd's management has provided the following forward guidance
Atul Ltd's most important sub-sector-specific KPIs from the latest concall
Based on quantitative research signals, here is why Atul Ltd may be worth studying
Atul Ltd investment thesis summary:
Atul Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.